{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:06Z","timestamp":1786991466776,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["TI084938"],"award-info":[{"award-number":["TI084938"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010067","name":"University of Louisiana Monroe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.japh.2025.102945","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T23:29:27Z","timestamp":1760657367000},"page":"102945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Equipping the front lines: Building a harm reduction program for Louisiana first responders"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0426-4439","authenticated-orcid":false,"given":"Alexis E.","family":"Horace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4536-5527","authenticated-orcid":false,"given":"Jameshia","family":"Below","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-9678","authenticated-orcid":false,"given":"Stephen","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2025.102945_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2016.05.008","article-title":"Training law enforcement to respond to opioid overdose with naloxone: impact on knowledge, attitudes, and interactions with community members","volume":"165","author":"Wagner","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"4S","key":"10.1016\/j.japh.2025.102945_bib5","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.japh.2019.04.011","article-title":"First responder knowledge, perception and confidence in administering naloxone: impact of a pharmacist-provided educational program in rural Mississippi","volume":"59","author":"Crocker","year":"2019","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"10","key":"10.1016\/j.japh.2025.102945_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271418","article-title":"A measurement invariance analysis of selected Opioid Overdose Knowledge Scale (OOKS) items among bystanders and first responders","volume":"17","author":"Swartz","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.japh.2025.102945_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1353\/cpr.2023.a900206","article-title":"Web-based naloxone training for law enforcement officers: a pilot feasibility study","volume":"17","author":"Dahlem","year":"2023","journal-title":"Prog Community Health Partnersh"},{"issue":"1","key":"10.1016\/j.japh.2025.102945_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40352-023-00250-9","article-title":"Effectiveness of take ACTION online naloxone training for law enforcement officers","volume":"11","author":"Khadr","year":"2023","journal-title":"Health Justice"},{"key":"10.1016\/j.japh.2025.102945_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/00220426251353368","article-title":"Police officer overdose response training","author":"Jacobson","year":"2025","journal-title":"J Drug Issues"},{"key":"10.1016\/j.japh.2025.102945_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2014.10.026","article-title":"Police officer attitudes towards intranasal naloxone training","volume":"146","author":"Ray","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.japh.2025.102945_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12954-022-00682-w","article-title":"Naloxone administration by law enforcement officers in New York State (2015-2020)","volume":"19","author":"Pourtaher","year":"2022","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.japh.2025.102945_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drugalcdep.2016.03.011","article-title":"An initial evaluation of law enforcement overdose training in Rhode Island","volume":"162","author":"Saucier","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.japh.2025.102945_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.drugalcdep.2013.02.007","article-title":"Development of opioid overdose knowledge (OOKS) and attitudes (OOAS) scales for take-home naloxone training evaluation","volume":"132","author":"Williams","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.japh.2025.102945_bib15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ajem.2015.05.022","article-title":"Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths","volume":"33","author":"Rando","year":"2015","journal-title":"Am J Emerg Med"},{"issue":"11","key":"10.1016\/j.japh.2025.102945_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/21650799231188364","article-title":"First responder attitudes regarding working near a supervised injection facility: relationship to burnout, secondary traumatic stress, and compassion satisfaction","volume":"71","author":"Pennington","year":"2023","journal-title":"Workplace Health Saf"},{"issue":"3","key":"10.1016\/j.japh.2025.102945_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3821\/145.3.cpj124","article-title":"Pharmacists and harm reduction: a review of current practices and attitudes","volume":"145","author":"Watson","year":"2012","journal-title":"Can Pharm J (Ott)"},{"issue":"1","key":"10.1016\/j.japh.2025.102945_bib18","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.22374\/jmhan.v3i1.37","article-title":"Harm reduction, stigma and the problem of low compassion satisfaction","volume":"3","author":"Knaak","year":"2019","journal-title":"J Ment Health Addict Nurs"},{"issue":"4","key":"10.1016\/j.japh.2025.102945_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajim.23224","article-title":"Working near a supervised injection facility: a qualitative study of perspectives of firefighter-emergency medical responders","volume":"64","author":"Pennington","year":"2021","journal-title":"Am J Ind Med"},{"issue":"10","key":"10.1016\/j.japh.2025.102945_bib20","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1080\/10826084.2022.2092150","article-title":"First responders' views of naloxone: does stigma matter?","volume":"57","author":"Kruis","year":"2022","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.japh.2025.102945_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ssmqr.2024.100421","article-title":"Financial barriers, facilitators, and strategies among syringe services programs in the U.S., and their impact on implementation and health outcomes","volume":"5","author":"Akiba","year":"2024","journal-title":"SSM Qual Res Health"},{"key":"10.1016\/j.japh.2025.102945_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2022.107034","article-title":"Support for evidence-informed opioid policies and interventions: the role of racial attitudes, political affiliation, and opioid stigma","volume":"158","author":"Pyra","year":"2022","journal-title":"Prev Med"},{"key":"10.1016\/j.japh.2025.102945_bib23","author":"Gerstel-Friedman"},{"issue":"1","key":"10.1016\/j.japh.2025.102945_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jrh.12129","article-title":"Barriers and facilitators to substance use treatment in the rural South: a qualitative study","volume":"32","author":"Brown","year":"2016","journal-title":"J Rural Health"},{"key":"10.1016\/j.japh.2025.102945_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.apnu.2023.09.001","article-title":"Substance use and opioid-related stigma among Black communities in the rural South","volume":"46","author":"Cody","year":"2023","journal-title":"Arch Psychiatr Nurs"},{"key":"10.1016\/j.japh.2025.102945_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108488","article-title":"Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: a qualitative analysis","volume":"130","author":"Burgess","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.japh.2025.102945_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamapsychiatry.2013.3575","article-title":"Race\/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States","volume":"71","author":"Cummings","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.japh.2025.102945_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.112430","article-title":"Racialized environments and syringe services program implementation: county-level factors","volume":"263","author":"Bluthenthal","year":"2024","journal-title":"Drug Alcohol Depend"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:55:51Z","timestamp":1769111751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125006247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1544319125006247"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102945","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Equipping the front lines: Building a harm reduction program for Louisiana first responders","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102945"}}